Bold Capital Enterprises Ltd (BOLD.P) Quote

If Missling focused on just two or three programs addressing rare diseases, funded and conducted clinical trials the right way, and produced credible results in a timely manner, big investors (and potential pharma partners) would be pounding down the door to give him money. Instead, he has to raise

So you promote those other companies on this, the KBLB stock message board, because you believe their capabilities of bringing Spider Silk to market are better than KBLB'S and that they will succeed while KBLB won't?

You seem to have a problem with everything. Sell and leave .. Bye..🖐️

Big news around here and they can't get rid of her...you know why? Everyone wants a part of what she got.

"I want in on the scam too!"

It's IL ....not FL.

Sorry our year has been delayed til 2037, further details will come, JB is still stepping down and Frank has had 12 more failed schemes.

RONN subsequently going to initiate a reverse split.

Well it won't be anytime soon always pessimistic aren't you... this is not the market for you. (JMO) RONN

Bar, >> Ulta, Heico

Yes MULTIPLE MERGERS enroute. Beyond stoked with this one.

You should sell and leave too. Bye...🖐️

sideeki: Well, I might have to ride side Saddle!!!

Sound like alot of mergers

WE ARE GOLDEN…

ENJOY Everyone…

😀

Pump.fun killing memes right now

Ah. I see. It actually took years for BPs.

Oh wow. Tomorrow will be a great day.

company plans to engage with a list of acquisition and industry professionals to fill the independent seats on its Board, as required by OTC Markets for OTCQB listing.  The company will give this plan top priority. I really like that part of pr

We've been through this before with the non selling HealFast that BIEL dropped years ago from their line up of products. So, anything new will fall to the same demise.

DesertDrifter: Glad I went in. Change a few minds!!!!

I don’t know what to think anymore absolutely ridiculous situation.

I have no problem with a P2 that is designed to both surface any AERs and give meaningful efficacy signals. It doesn't need to be large. The P3 pivotal trial(s) need to be large enough to de-risk the basis for regulatory approval. I think the schizophrenia trial may be very well designed. Now, w

Lol... Just scream at everybody...

..


.

Id say his follow through is about 50/50 on time/schedule

BULLCHIT... THAT IS WRONG!!! all the time on a time and his schedule, you weren't even here when news has come out, how do you even feel qualified to comment on this question?? when he puts out news it is usually on a Tuesday o

The lesson Missling has learned is that he can get away with just about anything because his loyal followers hold him accountable for nothing.